Glucagon Like Peptide-1 (GLP-1) Modulates OVA-Induced Airway Inflammation and Mucus Secretion Involving a Protein Kinase A (PKA)-Dependent Nuclear Factor-κB (NF-κB) Signaling Pathway in Mice
Open accessThe DOI matches its Crossref record; 56 of the 58 references it cites were found in a registry or an index.
Abstract
Asthma is a common chronic pulmonary inflammatory disease, featured with mucus hyper-secretion in the airway. Recent studies found that glucagon like peptide-1 (GLP-1) analogs, including liraglutide and exenatide, possessed a potent anti-inflammatory property through a protein kinase A (PKA)-dependent signaling pathway. Therefore, the aim of current study was to investigate the value of GLP-1 analog therapy liraglutide in airway inflammation and mucus secretion in a murine model of ovalbumin (OVA)-induced asthma, and its underlying molecular mechanism. In our study, BALB/c mice were sensitized and challenged by OVA to induce chronic asthma. Pathological alterations, the number of cells and the content of inflammatory mediators in bronchoalveolar lavage fluid (BALF), and mucus secretion were observed and measured. In addition, the mRNA and protein expression of E-selectin and MUC5AC were analyzed by qPCR and Western blotting. Then, the phosphorylation of PKA and nuclear factor-κB (NF-κB) p65 were also measured by Western blotting. Further, NF-κB p65 DNA binding activity was detected by ELISA. OVA-induced airway inflammation, airway mucus hyper-secretion, the up-regulation of E-selectin and MUC5AC were remarkably inhibited by GLP-1 in mice (all p < 0.01). Then, we also found that OVA-reduced phosphorylation of PKA, and OVA-enhanced NF-κB p65 activation and NF-κB p65 DNA binding activity were markedly improved by GLP-1 (all p < 0.01). Furthermore, our data also figured out that these effects of GLP-1 were largely abrogated by the PKA inhibitor H-89 (all p < 0.01). Taken together, our results suggest that OVA-induced asthma were potently ameliorated by GLP-1 possibly through a PKA-dependent inactivation of NF-κB in mice, indicating that GLP-1 analogs may be considered an effective and safe drug for the potential treatment of asthma in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Liraglutide (2 mg/kg) reduced immune cell infiltration and protein expression of E-selectin, TNF-α, IL-4, IL-5, and IL-13 in the lung tissue or bronchoalveolar lavage fluid in an ovalbumin-induced chronic asthma model.”
From Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control (2016) · cites this paper as [110]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Hattori, Y., Jojima, T., Tomizawa, A., Satoh, H., Hattori, S., Kasai, K., & Hayashi, T. (2010) · Diabetologia · doi:10.1007/s00125-010-1831-8 · Cited by 183
RetractedThe prevalence of severe refractory asthma
Hekking, P.-P. W., Wener, R. R., Amelink, M., Zwinderman, A. H., Bouvy, M. L., & Bel, E. H. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.08.042 · Cited by 813
Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor
Bullock, B. P., Heller, R. S., & Habener, J. F. (1996) · Endocrinology · doi:10.1210/en.137.7.2968 · Cited by 618 · cited 1×
“Therefore, these findings, in consistent with the previous studies, indicated that GLP-1R should exist on airway epithelial cells [14,15,31].”
ResultArakawa, M., Mita, T., Azuma, K., Ebato, C., Goto, H., Nomiyama, T., Fujitani, Y., Hirose, T., Kawamori, R., & Watada, H. (2010) · Diabetes · doi:10.2337/db09-1694 · Cited by 548 · cited 1×
“[24] showed that LPS-induced macrophage activation and TNF-α expression was significantly reduced by”
BackgroundSvegliati‐Baroni, G., Saccomanno, S., Rychlicki, C., Agostinelli, L., De Minicis, S., Candelaresi, C., Faraci, G., Pacetti, D., Vivarelli, M., Nicolini, D., et al. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02462.x · Cited by 405 · cited 1×
“[36] determined that exenatide could ameliorate nonalcoholic fatty liver disease”
BackgroundCampos, R. V. (1994) · Endocrinology · doi:10.1210/en.134.5.2156 · Cited by 353 · cited 1×
“Therefore, these findings, in consistent with the previous studies, indicated that GLP-1R should exist on airway epithelial cells [14,15,31].”
ResultcAMP regulation of airway smooth muscle function
Billington, C. K., Ojo, O. O., Penn, R. B., & Ito, S. (2013) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2012.05.007 · Cited by 240
Bao, Z., Guan, S., Cheng, C., Wu, S., Wong, S. H., Kemeny, D. M., Leung, B. P., & Wong, W. S. F. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200809-1516oc · Cited by 226 · cited 2×
“A number of studies proved that macrophages, neutrophils, eosinophils, and lymphocytes were the mainly immunological cells in airway inflammation in asthma [4,8,26].”
BackgroundAbdelsalam, R. M., & Safar, M. M. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13087 · Cited by 221 · cited 1×
“The amount of data also confirmed that PKA was essential for the modulation of NF-κB activation [28,51].”
BackgroundAndrographolide Protects against LPS-Induced Acute Lung Injury by Inactivation of NF-κB
Zhu, T., Wang, D.-X., Zhang, W., Liao, X.-Q., Guan, X., Bo, H., Sun, J.-Y., Huang, N.-W., He, J., Zhang, Y.-K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056407 · Cited by 210 · cited 1×
“Simultaneously, many studies determined that the de novo synthesis of TNF-α and E-selectin, the critical inflammatory molecules, were mainly regulated by NF-κB activation in ARDS and asthma [27,52,53].”
BackgroundSelf-citation
Cited by
Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control
Lee, Y.-S., & Jun, H.-S. (2016) · Mediators of Inflammation · doi:10.1155/2016/3094642 · Cited by 530
Koga, Y., Tsurumaki, H., Aoki‐Saito, H., Sato, M., Yatomi, M., Takehara, K., & Hisada, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061346 · Cited by 165
Emodin suppresses LPS-induced inflammation in RAW264.7 cells through a PPARγ-dependent pathway
Zhu, T., Zhang, W., Feng, S.-J., & Yu, H.-P. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.02.014 · Cited by 141
Self-citationGLP-1 receptor agonist as a modulator of innate immunity
Chen, J., Mei, A., Wei, Y., Li, C., Qian, H., Min, X., Yang, H., Dong, L., Rao, X., & Zhong, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.997578 · Cited by 120
“Frontiers in Immunology 05 showed that GLP-1R signaling inhibits the innate immune response in animal models of asthma, by the activation of PKA/NF-kB signaling pathway (99) and the decreased eosinophil production of IL-4, IL-8 and IL-13 (39).”
BackgroundPradhan, R., Lu, S., Yin, H., Yu, O. H. Y., Ernst, P., Suissa, S., & Azoulay, L. (2022) · BMJ · doi:10.1136/bmj-2022-071380 · Cited by 111
Metadata
- Authors
- Zhu, T., Wu, X.-L., Zhang, W., & Xiao, M.
- Affiliations
- West China Hospital of Sichuan University (CN)
- Department of Respiratory Medicine, and Division of Pulmonary Diseases, State Key Laboratory of Biotherapy of China, West China Hospital of Sichuan University, Chengdu 610041, China
- First Affiliated Hospital of Chengdu Medical College (CN)
- Corresponding author
- Xiao, Min
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2015-08-26
- Volume
- 16
- Issue
- 9
- Pages
- 20195-20211
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC4613197
- OpenAlex
- W1915288020
- Cited by
- 106
- References
- 58
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 10 · 2023: 10 · 2022: 13 · 2021: 13 · 2020: 11 · 2019: 9 · 2018: 9 · 2017: 5 · 2016: 4
- FWCI
- 4.42
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Applying Fundamental Research Foundation of Sichuan Province of China (2013JY0032)
- China Postdoctoral Science Foundation (2014M552369)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- glucagon-like peptide-1, liraglutide, asthma, airway inflammation, mucus hypersecretion, ovalbumin-induced asthma, protein kinase A, NF-κB signaling, NF-κB p65, E-selectin, MUC5AC, H89, anti-inflammatory therapy
- MeSH terms
- Animals, Asthma, Bronchoalveolar Lavage Fluid, Disease Models, Animal, Leukocyte Count, Leukocytes, Mucus, Ovalbumin, Signal Transduction, Cytokines, NF-kappa B, Cyclic AMP-Dependent Protein Kinases, Inflammation Mediators, E-Selectin, Mice, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glucagon Like Peptide-1 (GLP-1) Modulates OVA-Induced Airway Inflammation and Mucus Secretion Involving a Protein Kinase A (PKA)-Dependent Nuclear Factor-κB (NF-κB) Signaling Pathway in Mice. https://app.cochat.ai/papers/10.3390/ijms160920195
- The paper
- Zhu, T., Wu, X.-L., Zhang, W., & Xiao, M. (2015). Glucagon Like Peptide-1 (GLP-1) Modulates OVA-Induced Airway Inflammation and Mucus Secretion Involving a Protein Kinase A (PKA)-Dependent Nuclear Factor-κB (NF-κB) Signaling Pathway in Mice. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms160920195
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.